And everyone in the study had diabetes, so no one was taking these medications solely for weight loss
North Carolina eliminated GLP-1 coverage beginning October 2025 due to a budget stalemate in the legislature, but coverage was reinstated in December 2025, bringing the total number of states covering GLP-1s for obesity to 13 as of January 2026
Thats all to say that the weight loss effects, I think by now everyone knows, are unprecedented and transformative, almost really to the same level as going for bariatric surgery
While the softgels are large, they're surprisingly easy to swallow, and the lemon essence covers up any fishy taste or aftertaste
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes
Track this daily for the first three months, then weekly once patterns stabilize